Positional Obstructive Sleep Apnea (POSA) is a specific diagnosis where breathing obstructions can occur more frequently when sleeping on you back. Individuals with POSA require a different treatment than those with OSA – the goal being to control sleep positions during the night.
Location: Netherlands, South Holland
Employees: 11-50
Total raised: $13.9M
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | Gilde Heal... | gildehealt... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.07.2016 | Series B | $13.9M | - |
Mentions in press and media 5
| Date | Title | Description |
| 28.11.2018 | The Innovators Under 35 Europe 2018 | Technology to eliminate the waste of food, solar strips to regenerate burned skin faster and artificial intelligence that analyzes electrocardiograms as well as a real doctor, among the winning projects The European community will meet on ... |
| 29.07.2016 | Digital health companies raised more than $149M in July | During the month of July, MobiHealthNews reported on 16 digital health companies that raised venture funding. The deals total $149.3 million, which is lower on average when compared to other months this year so far but that's expected for t... |
| 05.07.2016 | Sleep apnea wearable company NightBalance raises $13.9M | Sleep apnea device developer NightBalance announced today it has raised $13.9 million (EU €12.5 million) in second round funding led by INKEF Capital and Gilde Healthcare Partners. The Dutch company will use the funds to further advance the... |
| 05.07.2016 | NightBalance closes €12.5 million Series B financing to expand internationally with its sleep apnea device | NightBalance, a leading innovator of obstructive sleep apnea (OSA) technology, today announced the completion of a €12.5 million Series B financing round led by INKEF Capital and Gilde Healthcare Partners. Existing investors Thuja Capital, ... |
| 05.07.2016 | Obstructive Sleep Apnea Technology Provider NightBalance Raises €12.5M | NightBalance BV, a Delft, The Netherlands-based provider of obstructive sleep apnea (OSA) technology, completed a €12.5m Series B financing. The round was led by Inkef Capital and Gilde Healthcare Partners with participation from existing i... |